Deficiency of PTEN and CDKN2A Tumor-Suppressor Genes in Conventional and Chondroid Chordomas: Molecular Characteristics and Clinical Relevance.
Chenlong YangJianjun SunLei YongChen LiangTie LiuYulun XuJun YangXiaoguang LiuPublished in: OncoTargets and therapy (2020)
Our findings delineated the genetic landscape and expression of PTEN and CDKN2A in chordomas. PTEN expression may serve as a prognostic and predictive biomarker for chordomas.